Click any tag below to further narrow down your results
Links
@_catwu on X
Cat Wu, a product leader, announces she is joining OpenAI to lead product management for its Core Products team. She says she'll work with Thibault Sottiaux and build agents designed to help people and their teams while keeping them in control.
- Wu will lead product management for OpenAI's Core Products, working alongside Thibault Sottiaux (@thsottiaux) and the existing PM team.
- She credits OpenAI with proving that scaling works and with bringing AI to over a billion people.
- The stated goal is agents that support users and their teams, keep users in control, and free up time for work and people they care about.
OpenAI has bought Orchestra Bio, a platform that helps biopharma teams coordinate drug programs across departments and partners. The plan is to combine it with Rosalind, OpenAI's life sciences AI, so agents can track studies and flag problems before they stall a program.
- Drug development typically takes 10 to 15 years from target discovery to US regulatory approval, and teams often juggle disconnected systems across internal departments and outside partners.
- Orchestra's agents monitor studies and timelines, so when something breaks, like a failed manufacturing batch that delays a clinical trial, they show which activities are affected and compare ways to respond.
- The longer goal is AI that helps with the whole process, from exploring ideas and designing experiments to interpreting results and coordinating the work.
@wulfie_bain_ on X
An OpenAI Startups applied AI lead argues that prompts in even the best AI companies grow contradictory over time because teams only add lines and never remove them. He proposes treating prompts like code and product decisions, using a modular, MECE structure (Background, Behaviour, Output).
- Prompts evolve accretively, so contradictions and ambiguity pile up. Conditional prompts spread across files make the whole thing hard for anyone to review end to end.
- He reports results from prompt rewrites: one startup cut agent speed-ups of about 50%, another saw 40% higher 7-day retention, and another cut costs by 30%.
- Smarter models don't fix ambiguity. Someone still has to specify what the product should do, and evals force that clarity.